Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Jonsson Comprehensive Cancer Center
Novelty Nobility, Inc.
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Vanderbilt-Ingram Cancer Center
Merck Sharp & Dohme LLC